US Stock MarketDetailed Quotes
DERM Journey Medical
- 4.830
- +0.320+7.10%
Close Aug 23 16:00 ET
100.11MMarket Cap37.15P/E (TTM)
4.870High4.430Low117.04KVolume4.520Open4.510Pre Close541.93KTurnover1.14%Turnover RatioLossP/E (Static)20.73MShares8.11052wk High8.86P/B49.57MFloat Cap1.92052wk Low--Dividend TTM10.26MShs Float10.200Historical High--Div YieldTTM9.76%Amplitude1.020Historical Low4.630Avg Price1Lot Size
Journey Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -230.41%-5.18M | -425.00%-5.02M | 138.72%5.24M | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | -208.14%-956K | -520.54%-13.53M | -19.65%-3.84M | -202.53%-7.28M |
| Net income from continuing operations | 59.81%-3.36M | -3.02%-10.44M | 87.00%-3.85M | 79.86%-2.14M | 266.56%16.79M | -11.09%-8.36M | -635.56%-10.14M | 32.65%-29.63M | 51.07%-10.64M | 5.32%-10.08M |
| Depreciation and amortization | -23.03%839K | -23.37%836K | -11.68%3.86M | -32.85%838K | -19.54%836K | 4.91%1.09M | 5.00%1.09M | 70.51%4.37M | 143.27%1.25M | 52.79%1.04M |
| Other non cash items | -82.07%64K | -46.09%62K | -14.89%709K | -98.80%2K | 7.80%235K | 54.55%357K | -47.00%115K | -95.84%833K | -95.72%167K | -98.03%218K |
| Change In working capital | -170.67%-4.54M | -56.78%3.11M | -126.75%-1.66M | -526.68%-15.69M | 756.25%411K | 198.24%6.42M | 2,230.74%7.2M | -57.94%6.19M | 20.08%3.68M | -99.49%48K |
| -Change in receivables | -107.78%-812K | 1,062.45%5.42M | 333.29%12.55M | -14,170.59%-7.18M | 10,538.55%8.83M | 320.44%10.43M | 105.83%466K | -800.52%-5.38M | -99.40%51K | 101.50%83K |
| -Change in inventory | -19.69%893K | -142.45%-374K | 126.66%3.95M | -23.62%818K | 38.76%1.14M | 1,223.81%1.11M | 476.50%881K | 120.62%1.74M | -38.87%1.07M | -69.53%823K |
| -Change in prepaid assets | -74.89%171K | 21.51%1.01M | 67.97%-279K | -12.55%-2.66M | 837.63%872K | 18.85%681K | 0.24%832K | -12.53%-871K | -149.68%-2.37M | 111.98%93K |
| -Change in payables and accrued expense | 17.56%-4.77M | -157.91%-2.92M | -265.80%-17.8M | -234.60%-6.64M | -1,014.56%-10.41M | -497.11%-5.78M | -34.58%5.04M | -54.13%10.73M | 172.27%4.94M | -106.88%-934K |
| -Change in other current assets | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 138.19%55K | -98.66%8K | 101.17%7K |
| -Change in other current liabilities | -8.70%-25K | -71.43%-24K | 12.63%-83K | -4.55%-23K | 4.17%-23K | 8.00%-23K | 41.67%-14K | -13.10%-95K | 0.00%-22K | -4.35%-24K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -230.41%-5.18M | -425.00%-5.02M | 138.72%5.24M | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | -208.14%-956K | -520.54%-13.53M | -19.65%-3.84M | -202.53%-7.28M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 75.00%-5M | 0 | 0 | 0 | 75.00%-5M | -100.00%-20M | 0 | 0 |
| Net intangibles purchase and sale | --0 | --0 | 75.00%-5M | --0 | --0 | --0 | 75.00%-5M | -100.00%-20M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 75.00%-5M | --0 | --0 | --0 | 75.00%-5M | -100.00%-20M | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 138.44%5.03M | 3,048.08%1.64M | -129.19%-4.8M | 1,926.37%19.21M | -372.34%-10.98M | -11,890.99%-13.09M | -99.54%52K | -68.96%16.46M | -97.02%948K | -64.04%4.03M |
| Net issuance payments of debt | 138.46%5M | --0 | -152.95%-8.95M | 1,482.28%15M | -375.00%-11M | ---13M | -99.56%52K | 234.50%16.9M | 16.75%948K | -43.18%4M |
| Net common stock issuance | --0 | --1.48M | --4.49M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 933.33%31K | --153K | -14.79%121K | --96K | -29.03%22K | --3K | --0 | 1,928.57%142K | --0 | --31K |
| Net other financing activities | ---- | ---- | 19.49%-471K | ---380K | --0 | ---- | ---- | 83.50%-585K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 138.44%5.03M | 3,048.08%1.64M | -129.19%-4.8M | 1,926.37%19.21M | -372.34%-10.98M | -11,890.99%-13.09M | -99.54%52K | -68.96%16.46M | -97.02%948K | -64.04%4.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.82%24.06M | -14.26%27.44M | -34.80%32M | -29.07%24.75M | -55.48%16.98M | -36.85%26.1M | -34.80%32M | 495.21%49.08M | 60.87%34.89M | 213.26%38.14M |
| Current changes in cash | 98.41%-145K | 42.72%-3.38M | 73.28%-4.56M | 193.14%2.69M | 338.97%7.77M | -185.95%-9.12M | 23.82%-5.9M | -141.82%-17.08M | -110.54%-2.89M | -134.17%-3.25M |
| End cash Position | 40.82%23.91M | -7.82%24.06M | -14.26%27.44M | -14.26%27.44M | -29.07%24.75M | -55.48%16.98M | -36.85%26.1M | -34.80%32M | -34.80%32M | 60.87%34.89M |
| Free cash flow | -230.41%-5.18M | 15.73%-5.02M | 100.72%240K | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | 68.84%-5.96M | -175.30%-33.53M | 12.94%-3.84M | -328.86%-7.28M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg